michael yee

Displaying 10 out of 3 results

  1. A company logo is seen at a Pfizer office in Dublin

    Pfizer's biosimilar of Amgen, J&J's anemia treatments gets FDA nod

    Pfizer Inc's biosimilar of anemia treatments from Amgen Inc and Johnson & Johnson was approved by U.S. health regulators on Tuesday setting it up ...
  2. New Content Item

    Biogen boosts investment in neurology with US$1 billion Ionis deal

  3. New Content Item

    Esperion's cholesterol drug succeeds in late-stage study